What should the morning NPH (Neutral Protamine Hagedorn) insulin dose be for a 65-year-old patient with type 1 diabetes, currently taking Lantus (insulin glargine) 8 units daily, hydrocortisone every 8 hours, with impaired renal function (creatinine level 4.61), and a carb ratio of 1:12 with medium correction factor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Morning NPH Insulin Dosing for Type 1 Diabetes with Steroid-Induced Hyperglycemia and Renal Impairment

Recommended AM NPH Dose

Start with 26-35 units of NPH insulin in the morning, calculated as 0.3-0.4 units/kg (87 kg × 0.3-0.4 = 26-35 units), specifically to counteract the steroid-induced hyperglycemia from hydrocortisone every 8 hours. 1

Rationale for This Dose

  • Morning NPH administration is specifically recommended for steroid-induced hyperglycemia to match the pharmacokinetic profile of glucocorticoids, which peak 4-8 hours after administration 1, 2

  • The standard starting dose of 0.1-0.2 units/kg (8.7-17.4 units) is insufficient for patients on high-dose glucocorticoids, who require 40-60% more insulin than standard dosing 2

  • For high-dose glucocorticoid therapy, initial NPH dosing should be 0.3-0.4 units/kg per day, which for this 87 kg patient equals 26-35 units 1

  • The current Lantus dose of 8 units daily should be continued as basal coverage, with the NPH added specifically to address the steroid effect 1

Critical Adjustments for Renal Impairment (Cr 4.61)

  • Reduce the calculated dose by 20% due to severe renal impairment (CrCl significantly reduced with Cr 4.61), bringing the starting dose to approximately 21-28 units 3

  • Patients with impaired renal function have increased risk of hypoglycemia due to decreased insulin clearance and impaired renal gluconeogenesis 3

  • Morning administration is particularly important in renal impairment to allow better monitoring during waking hours and reduce risk of undetected nocturnal hypoglycemia 3

Practical Starting Recommendation

Begin with 24 units of NPH insulin in the morning (mid-range of the adjusted 21-28 unit calculation), administered at the same time as the morning hydrocortisone dose.

Titration Protocol

  • Increase by 2 units every 3 days until fasting plasma glucose reaches target (100-180 mg/dL for this post-transplant-like scenario) without hypoglycemia 4, 3

  • If hypoglycemia occurs, reduce the dose by 10-20% immediately 4, 1, 2, 3

  • Monitor blood glucose every 4-6 hours during initial titration, particularly important given the renal impairment 1, 3

Adjusting the Carbohydrate Ratio

  • The current 1:12 carb ratio is too conservative for high-dose steroid therapy

  • Change to 1:8-10 carb ratio (more aggressive) to account for steroid-induced insulin resistance 1

  • For meals with greatest postprandial excursions, consider 1:6 ratio 1

  • As steroids are tapered, the carb ratio should be liberalized back toward 1:10-12 2

Correction Factor Adjustment

  • The "medium correction" needs to be more aggressive on steroids

  • Use the 1800 rule: 1800 ÷ total daily insulin dose = correction factor 1

  • With current total daily dose of approximately 32-40 units (8 units Lantus + 24 units NPH + prandial insulin), correction factor should be approximately 1 unit per 45-56 mg/dL above target 1

  • Recommended correction scale for blood glucose >150 mg/dL:

    • 150-200 mg/dL: 2 units 1
    • 201-250 mg/dL: 4 units 1
    • 251-300 mg/dL: 6 units 1
    • 301-350 mg/dL: 8 units 1
    • 350 mg/dL: 10 units and notify provider 1

Critical Considerations for This Complex Patient

Type 1 Diabetes Specifics

  • Never discontinue basal insulin (Lantus) even if NPH is added, as this patient has type 1 diabetes and requires continuous basal coverage to prevent diabetic ketoacidosis 4, 1

  • The 8 units of Lantus should continue unchanged initially, with NPH added on top specifically for steroid coverage 1

Steroid Tapering Protocol

  • As hydrocortisone is reduced, decrease NPH by 10-20% for each significant steroid dose reduction 1, 2

  • The Lantus dose should remain stable during steroid taper 1

  • Failing to reduce NPH as steroids taper is a common pitfall that leads to severe hypoglycemia 1, 2

Renal Function Monitoring

  • Insulin requirements may fluctuate with changes in renal function, requiring more frequent monitoring and dose adjustments 3

  • Prescribe glucagon for emergent hypoglycemia, particularly important given the renal impairment 3

  • Consider more frequent blood glucose checks (every 4 hours) rather than standard 6-hour intervals 3

Alternative Approach if Glycemic Control Inadequate

  • If once-daily morning NPH fails to achieve targets, convert to twice-daily NPH regimen: 2/3 of total dose in morning, 1/3 before dinner 4, 2

  • For conversion from once-daily to twice-daily NPH, use 80% of the current total NPH dose split as above 4

  • If hypoglycemia becomes problematic despite dose adjustments, consider switching to a long-acting basal analog after steroid discontinuation 4, 3

Common Pitfalls to Avoid

  • Failing to match NPH timing with steroid administration leads to inadequate coverage of steroid-induced hyperglycemia 1

  • Using bedtime NPH in renal impairment increases risk of undetected nocturnal hypoglycemia 3

  • Not reducing insulin doses proportionally during steroid taper results in severe hypoglycemia 1, 2

  • Discontinuing basal insulin (Lantus) in type 1 diabetes can precipitate diabetic ketoacidosis 4, 1

References

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Regimen for Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.